ProjectNICCI - ML29328
Basic data
Title:
NICCI - ML29328
Duration:
01/04/2017 to 31/12/2020
Abstract / short description:
A PHASE II, SINGLE-ARMED, MULTICENTER TRIAL OF NEOADJUVANT VISMODEGIB IN PATIENTS WITH LARGE AND/OR RECURRENT RESECTABLE BASAL CELL CARCINOMA
– NICCI -
A trial of the Arbeitsgemeinschaft Dermatologische Onkologie (ADO)
– NICCI -
A trial of the Arbeitsgemeinschaft Dermatologische Onkologie (ADO)
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Gießen, Hessen, Germany